Johnson & Johnson Headquarters at One Johnson and Johnson... 5 Shareholders lawsuit 6.6 Illegal marketing of Risperdal 6.7... 12 Vaginal mesh implants 6.13 Baby powder 6.14 Opioid epidemic...
[1] Together with toxic epidermal necrolysis (TEN) and Stevens–Johnson/toxic epidermal necrolysis (SJS/TEN) overlap, they are considered febrile mucocutaneous drug reactions and probably...
Johnson and Johnson faces lawsuit over vaginal mesh devices
Petitions of the week ; The Petitions of the Week column highlights a selection of cert petitions recently filed in the Supreme Court. A list of all petitions we’re watching is available here. In April 2019, the Food and Drug Administration ordered the end of sales of pelvic mesh , a medical device marketed to help women with certain urinary or vaginal conditions, to treat a common ailment called pelvic organ prolapse. The move came in response to a tide of lawsuits brought against manufacturers of the technology by women who alleged serious ...
Johnson & Johnson is stopping sales of surgical mesh products that aimed to relieve the intense pelvic pain of thousands of women but resulted in numerous reports of injury and several deaths
The US Supreme Court rejected a Johnson & Johnson appeal, leaving intact a $302 million award against the company for misrepresenting the risks of vaginal-mesh implants to California consumers.
UK and US. More than 100,000 transvaginal mesh lawsuits have been filed in the US, the largest number against Johnson & Johnson, the manufacturer of the most commonly used meshes. Shine...
He was interested in talking to her about a lawsuit against Johnson & Johnson; she wasn’t convinced he was a real lawyer. Smith did in fact practice law, and, years before, his father, a...
Officials in Washington state and California say the mesh, made by Johnson & Johnson, caused dire complications
Johnson & Johnson—the total number of pending claims against the company is 100,000 and growing—the pileup of bad... vaginal mesh implant, used to strengthen weak pelvic muscles. Almost...